Thus, the effect of FABP12 on PCa lipid metabolism, metastasis, and treatment resistance may be at least partially mediated through binding of FABP12 ligands (or their metabolites) to PPARγ. The gene discussed is PPARG; the disease is posterior cortical atrophy.